Immunotherapy Drug Atezolizumab Beats Standard Chemo for Certain Lung Cancer Patients

Lung Cancer Treatment Plans Changed Due to Pandemic – 57 percent of patients receiving active treatment had at least one change in treatment plans

More Than Half of Cancer Patients Willing to Enroll in Clinical Trials

Participation rates similar for Black and White patients, treatment and cancer control trials

COVID-19-Free Surgical Pathways May Aid Cancer Surgery Outcomes

Pulmonary complication, postoperative SARS-CoV-2 infection rates lower with COVID-19-free pathways

One Size May Not Fit All for Postoperative Opioid Prescribing

Guidelines reduce postoperative opioid prescribing but may result in inadequate pain control for some

Certain HTN Meds May Cut Deaths From Influenza, Pneumonia

Use of ACE-I/ARB versus nonuse linked to lower mortality for those hospitalized with flu, pneumonia

Bedside Tracheotomy Feasible for Critically Ill COVID-19 Patients

No infection identified among surgeons following procedure; postoperative complications rarely seen

Remdesivir Cuts Time to COVID-19 Recovery

However, no significant difference in mortality found between remdesivir and placebo groups

Exercise Intensity Seems Not to Impact Mortality Levels

Combined MICT, HIIT intervention group had no difference in mortality versus recommended guidelines

Poll: Medication Management Lacking in Older Adults

Most older adults taking multiple medications have never had a comprehensive medication review